CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Gladstone Institutes, J. David |
Dr. Steve M. Finkbeiner |
Foundation – Discovery Stage Research Projects |
Lewy body dementia, 𝛼-synuclein, and cell-specific mechanisms of neurodegeneration |
$1,739,760 |
Minutia, Inc. |
Katy Digovich |
Foundation – Discovery Stage Research Projects |
Immune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression |
$1,192,586 |
University of California, San Francisco |
Tomasz Nowakowski |
Foundation – Discovery Stage Research Projects |
Neuroimmune interactions in the developing human brain |
$1,626,000 |
University of California, Los Angeles |
Dr. M. Carrie Miceli |
Foundation – Discovery Stage Research Projects |
Interrogating Satellite Cell and Myofiber Defects and Repair in Human DMD using Single Nuclei/Single Cell RNA Sequencing of Muscle Resident Cells |
$1,578,000 |
University of California, San Diego |
Dr Marianna Alperin |
Foundation – Discovery Stage Research Projects |
Harnessing the rejuvenating capacity of pregnancy-associated factors to restore aged stem cell function |
$1,539,520 |
Sanford Burnham Prebys Medical Discovery Institute |
Aniruddha Deshpande |
Foundation – Discovery Stage Research Projects |
Investigating the SGF29/SAGA complex in regulation of normal and cancer stem cells |
$1,547,999 |
Cedars-Sinai Medical Center |
Tyler Mark Pierson |
Foundation – Discovery Stage Research Projects |
Modeling of GATAD2B-associated neurodevelopmental disorder and NuRDopathies: Investigation of cellular & molecular anomalies altering neurodevelopment |
$1,318,441 |
University of California, Los Angeles |
Michael F Wells |
Foundation – Discovery Stage Research Projects |
Village-based identification of human risk factors for viral neuropathogenesis |
$1,577,448 |
City of Hope, Beckman Research Institute |
Qiong Annabel Wang |
Foundation – Discovery Stage Research Projects |
Utilizing Age-Specific Adipocyte Progenitor Cells for Cell Therapy in Older Patients |
$1,508,997 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Denise Al Alam PhD |
Foundation – Discovery Stage Research Projects |
Modeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells |
$1,524,196 |
University of California, San Francisco |
Faranak Fattahi |
Foundation – Discovery Stage Research Projects |
hPSC-derived enteric ganglioids for cell therapy in gastrointestinal motility disorders |
$1,589,307 |
University of California, Los Angeles |
Dr. William Lowry Dr. |
Foundation – Discovery Stage Research Projects |
Defining the source of dysfunction in monogenic Intellectual Disability Syndrome neurons |
$1,500,337 |
University of California, Santa Cruz |
Maximilian Haeussler |
Foundation – Discovery Stage Research Projects |
An interactive data resource for hypothesis testing in stem cell single-cell gene expression and validation of the results with brain organoids |
$1,160,126 |
University of California, Los Angeles |
Dr. Kathrin Plath Dr. |
Foundation – Discovery Stage Research Projects |
Characterization and applications of human blastoids for understanding early human embryogenesis |
$1,402,137 |
University of California, San Francisco |
Tien Peng |
Foundation – Discovery Stage Research Projects |
Ex vivo fate mapping of human lung stem cell plasticity in fibrotic disease |
$1,625,998 |
University of California, Los Angeles |
Dr. Brigitte N Gomperts |
Foundation – Discovery Stage Research Projects |
Overcoming barriers for airway stem cell gene therapy for Cystic Fibrosis |
$1,472,858 |
University of California, San Francisco |
Erik Ullian |
Foundation – Discovery Stage Research Projects |
Modeling Retinitis Pigmentosa using patient-derived human iPSC organoids |
$1,380,543 |
University of California, Irvine |
Albert La Spada Ph.D. |
Foundation – Discovery Stage Research Projects |
Role of ataxin-3 polyadenylation site selection in ALS neuron toxicity and disease pathogenesis |
$1,514,416 |
University of California, Irvine |
Dr. Brian J. Cummings |
Foundation – Discovery Stage Research Projects |
Mapping the spatial and temporal responses of hESC-derived microglia to repeat mild closed head injury to identify therapeutic targets and mechanisms |
$1,339,685 |
University of California, San Francisco |
Tomasz Nowakowski |
Foundation – Discovery Stage Research Projects |
Identifying roadblocks to neural stem cell transplantation into human tissues. |
$1,551,394 |
Scripps Research Institute |
Xin Jin |
Foundation – Discovery Stage Research Projects |
Functional genomics to study cellular convergence across ASD risk genes in neurodevelopment |
$1,575,001 |
University of California, Los Angeles |
UCLA Gay M Crooks |
Foundation – Discovery Stage Research Projects |
Engineering pluripotent stem cells for universally available, off-the-shelf T cell therapies |
$1,352,753 |
University of California, San Diego |
Dr. Alon Goren |
Foundation – Discovery Stage Research Projects |
Establishment of a novel approach to systematically study the dynamic organization of protein complexes in stem cells |
$1,515,601 |
University of California, San Francisco |
Dr. Elizabeth Crouch |
Foundation – Discovery Stage Research Projects |
Harnessing vascular stem cells to grow and protect the human brain |
$1,391,998 |
University of California, Santa Cruz |
Dr. Camilla Forsberg |
Foundation – Discovery Stage Research Projects |
Determining how age-specific heterogeneity of human hematopoietic stem cells and megakaryocyte progenitors contribute to thrombotic disease upon aging |
$1,336,800 |
University of California, San Francisco |
Yin Shen PhD |
Foundation – Discovery Stage Research Projects |
Understanding Chemotherapy-Induced Peripheral Neuropathy Mechanisms using CRISPRi and Chemical Screens in Human iPSC-Derived Sensory Neurons |
$1,621,913 |
Cedars-Sinai Medical Center |
Dmitriy Sheyn |
Foundation – Discovery Stage Research Projects |
The role of WNT and BMP signaling pathways in iPSC to iTenocyte step-wise differentiation for tendon repair |
$1,516,563 |
Gladstone Institutes, J. David |
Julia Kaye |
Foundation – Discovery Stage Research Projects |
Developing a Human Model of Sporadic ALS Using Machine Learning and Robotic Microscopy |
$1,406,622 |
Greenstone Biosciences, Inc. |
Dr. Mukhtar Ahmed |
Foundation – Discovery Stage Research Projects |
Drug Discovery for Dilated Cardiomyopathy using Patient-Derived Human iPSCs |
$1,350,000 |
Stanford University |
Dr. Marius Wernig MD, PhD |
Foundation – Discovery Stage Research Projects |
Developing a microglia replacement therapy |
$1,378,365 |
University of California, San Diego |
Heidi Cook-Andersen |
Foundation – Discovery Stage Research Projects |
Towards a trophectoderm stem-cell model representing human blastocysts of the highest implantation potential |
$1,584,000 |
University of California, San Diego |
Dr. Alexis Komor |
Foundation – Discovery Stage Research Projects |
Development of a stem-cell based approach to interpret global effects of genetic variants contributing to neurodevelopmental disease risk |
$1,518,982 |
University of California, San Francisco |
Dr. Robert Blelloch MD, PHD. |
Foundation – Discovery Stage Research Projects |
Development of universal off-the-shelf iPSC derived dendritic cells for use as patient specific anti-tumor vaccine |
$1,391,999 |
University of California, Berkeley |
Dr. Michael P. Rapé Dr. |
Foundation – Discovery Stage Research Projects |
Control of OCT4 abundance and function in human stem cells |
$1,234,023 |
University of California, San Francisco |
Harold A. Chapman |
Foundation – Discovery Stage Research Projects |
Modulation of human alveolar stem cells to promote lung regeneration and avoid pulmonary fibrosis |
$1,626,001 |
University of California, Los Angeles |
Dr Melissa Jan Spencer |
Foundation – Discovery Stage Research Projects |
Engineering AAV capsids for transduction of neural and muscle stem cells |
$999,999 |
University of California, San Diego |
Francesca Soncin |
Foundation – Discovery Stage Research Projects |
Drivers of trophoblast stem/progenitor cell identity in human placenta |
$993,881 |
University of California, Irvine |
Momoko Watanabe |
Foundation – Discovery Stage Research Projects |
Generation of cortical organoids with tunable areal identities by spatial engineering of morphogens |
$0 |
University of California, San Diego |
Dr. Steven F Dowdy |
Discovery Research Projects |
Development of Anti-COVID RNAi Therapeutics Using Human iPSC-Derived Alveolar Epithelial Cells |
$150,000 |
Celularity Inc. |
William van der Touw |
Clinical Trial Stage Projects |
A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 |
$315,000 |
University of California, San Francisco |
Dr. Michael Matthay MD |
Clinical Trial Stage Projects |
Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative) |
$699,798 |
City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Clinical Trial Stage Projects |
Evaluation and Characterization of SARS-CoV-2 Antibody in Convalescent Volunteer Plasma Donors for Potential Therapeutic Use |
$999,999 |
University of California, Los Angeles |
Dr. Vaithilingaraja Arumugaswami PhD |
Therapeutic Translational Research Projects |
COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage |
$349,999 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Evan Y. Snyder |
Discovery Research Projects |
Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy |
$228,229 |
University of California, Los Angeles |
Dr. Lili Yang |
Discovery Research Projects |
Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells |
$250,000 |
University of Southern California |
Preet M Chaudhary |
Discovery Research Projects |
Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2 |
$248,125 |
University of California, San Diego |
Dr Karen Christman |
Discovery Research Projects |
Pro-healing biomaterial for treating lung inflammation associated with COVID-19 |
$221,758 |
City of Hope, Beckman Research Institute |
Dr Jianhua Yu |
Discovery Research Projects |
Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19 |
$150,000 |
Stanford University |
Dr. Albert J Wong |
Discovery Research Projects |
Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2 |
$249,999 |
Stanford University |
Dr. Helen M Blau |
Discovery Research Projects |
Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy |
$149,996 |